•   
  •   
  •   

Canada Over-the-counter heartburn drug Zantac pulled in US, Canada

08:55  19 october  2019
08:55  19 october  2019 Source:   msn.com

Drugs, cash seized from Vancouver home linked to Chilliwack trafficking operation

  Drugs, cash seized from Vancouver home linked to Chilliwack trafficking operation Drugs, cash seized from Vancouver home linked to Chilliwack trafficking operationChilliwack RCMP say the seizure and arrests came during a multi-jurisdiction drug trafficking investigation involving Vancouver police.

Drugmaker Sanofi is recalling its over - the - counter heartburn drug Zantac in the U . S . and Canada because of possible contamination. The French company Friday, Oct. 18, 2019 joined other drugmakers that have recently recalled their versions of the popular heartburn and ulcer drug . less.

Drugmaker Sanofi is recalling its over - the - counter heartburn drug Zantac in the U . S . and Canada because of possible contamination. In this Sept. 30, 2019, file photo a box of Maximum Strength Zantac tablets is shown at a pharmacy in Miami Beach, Fla.

  Over-the-counter heartburn drug Zantac pulled in US, Canada © Provided by Canadian Press Enterprises Inc

Drugmaker Sanofi is recalling its over-the-counter heartburn drug Zantac in the U.S. and Canada because of possible contamination.

The French company Friday joined other drugmakers that have recently recalled their versions of the popular heartburn and ulcer drug.

In September, the Food and Drug Administration said a potentially cancer-causing chemical had been detected at low levels in prescription and over-the-counter versions of Zantac. The federal agency said consumers could consider taking another heartburn medicine or contact their doctor.

Health Canada also said it was investigating the possible presence of a carcinogen in some ranitidine drugs available by prescription and over-the-counter. The agency issued a precautionary request last month for companies to stop distributing the medication.

Several drugstore chains have already removed Zantac and generic versions from store shelves.

—With a file from The Canadian Press

The Associated Press

Ontario family hoping to raise $2 million for potential life-saving drug for 2-month-old daughter .
Eva Batista was diagnosed with Spinal Muscular Atrophy (SMA), which is a rare disease that attacks the body's muscles, at seven weeks old. The disease can often be fatal by the age of two.“I didn’t understand, I never heard of SMA before,” said Eva’s mom, Jessica Sousa Batista, while choking back tears.Jessica said Eva must be fed through a feeding tube. READ MORE: 21-year-old Ontario patient with SMA granted access to costly ‘miracle drug’ coverage Spinraza is a drug which is successfully being used to stop the progression of SMA but the patient must take it for life.

—   Share news in the SOC. Networks

Topical videos:

usr: 3
This is interesting!